On September 1, 2025, the Health Insurance Fund of the Federation of Bosnia and Herzegovina failed to deliver the following medicines to the University Clinical Center Tuzla (cytostatics and medicines for AIDS, hepatitis, inflammatory bowel diseases, pulmonary hypertension, immunoglobulin, coagulation disorders, immunosuppressants, cystic fibrosis, spinal muscular atrophy, and multiple sclerosis):
– Azacitidine
– Cytarabine
– Exemestane
– Entecavir
– Erlotinib
– Fulvestrant
– Irinotecan
– Carboplatin
– Megestrol (tablets)
– Oxaliplatin
– Rixathon
– Sunitinib 25 mg
– Tamoxifen
